However, our observations agree with others reporting that ASA administration impairs STIM1/Orai1 interaction, and hence, ASA reduces SOCE in colorectal cancer cells; meanwhile, other nonsteroidal anti-inflammatory drugs, such as sulindac, impair SOCE and STIM1 membrane translocation [39]. Here, ORAI1 is linked to colorectal cancer.